PACAP 38 as a modulator of immune and endocrine responses during LPS-induced acute inflammation in rats

Journal of Neuroimmunology

Volumn 177, Issue 1-2, 2006, Pages 76-84

  Bik, Wojciech ^a   Wolinska Witort, Ewa ^a   Pawlak, Joanna ^b   Skwarlo Sonta, Krystyna ^b   Chmielowska, Magdalena ^a   Martynska, Lidia ^a   Baranowska Bik, Agnieszka ^a   Baranowska, Boguslawa ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cytokines; Hormones; Inflammation; PACAP 38; Peritoneal leukocytes; Splenocytes

Indexed keywords

CORTICOSTERONE; CYTOKINE; GROWTH HORMONE; HORMONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LIPOPOLYSACCHARIDE; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; MALE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; GROWTH HORMONE; INFLAMMATION MEDIATORS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; PERITONITIS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, INBRED WKY; SPLEEN; THYROXINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746297634     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.04.013     Document Type: Article

References (45)

1. Abad C., Martinez C., Laceta J., Juarranz M.G., Delgado M., and Gomariz R.P. PACAP expression in the immune system. Neuroimmunomodulation 10 (2002-2003) 177-186
2. Basedovsky H.O., and Del Rey A. Immune-neuro-endocrine interactions: facts and hypothesis. Endocr. Rev. 17 (1996) 64-102
3. Bik W., Wolinska-Witort E., Chmielowska M., Baranowska-Bik A., Rusiecka-Kuczalek E., and Baranowska B. VIP can modulate immune and endocrine responses during lipopolysaccharide-induced acute inflammation. Neuroimmunomodulation 211 (2004) 358-364
4. Calder P.C., Costa-Rosa L.F., and Curi R. Effects of feeding lipids of different fatty acid compositions upon rat lymphocyte proliferation. Life Sci. 56 (1995) 455-463
5. Chiodera P., Volpi R., Capretti L., Caffarri G., Magotti M.G., and Coiro V. Effects of intravenously infused PACAP on adenohypophyseal hormone secretion in normal men. Neuroendocrinology 64 (1996) 242-246
6. Csaba Z., Csernus V., and Gerendai I. Local effect of PACAP and VIP on testicular function in immature and adult rats. Peptides 18 (1997) 1561-1567
7. Delgado M., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell mediated cytotoxicity by inhibiting Fas ligand expression. J. Immunol. 165 (2000) 114-123
8. Delgado M., and Ganea D. Inhibition of INFγ-induced Janus Kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J. Immunol. 165 (2000) 3051-3057
9. Delgado M., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating Polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. J. Immunol. 164 (2000) 1200-1210
10. Delgado M., and Ganea D. Inhibition of endotoxin-induced macrophage and chemokine production by VIP and PACAP in vitro and in vivo. J. Immunol. 167 (2001) 966-975
11. Delgado M., De la Fuente M., Martinez C., and Gomariz R.P. Pituitary adenylate cyclase-activating peptides (PACAP 27 and PACAP 38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP. J. Neuroimmunol. 62 (1995) 137-146
12. Delgado M., Munoz-Elias E.J., Kan Y., Gozes I., Fridkin M., Brenneman D.E., Gomariz R.P., and Ganea D. VIP and PACAP inhibit tumor necrosis factor α transcriptional activation by regulating nuclear factor-κB and cAMP response element-binding protein/c Jun. J. Biol. Chem. 273 (1998) 31427-31436
13. Delgado M., Leceta J., Abad C., Martinez C., Ganea D., and Gomariz R.P. Shedding of membrane-bound CD14 from LPS-stimulated macrophages by VIP and PACAP. J. Neuroimmunol. 99 (1999) 61-71
14. Delgado M., Leceta J., Gomariz R.P., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J. Immunol. 163 (1999) 3629-3635
15. Delgado M., Martinez C., Pozo D., Calvo J.R., Leceta J., Ganea D., and Gomariz R.P. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNFα and IL6. J. Immunol. 162 (1999) 1200-1205
16. Delgado M., Munoz-Elias E.J., Gomariz R.P., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and IFN regulatory factor 1 activation. J. Immunol. 162 (1999) 4685-4696
17. Delgado M., Munoz-Eliaz E.J., Gomariz R.P., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL10 production by murine macrophages: in vitro and in vivo studies. J. Immunol. 162 (1999) 1707-1716
18. Delgado M., Munoz-Eliaz E.J., Gomariz R.P., and Ganea D. VIP and PACAP inhibit IL12 production in LPS-stimulated macrophages. Subsequent effects on INFγ synthesis by T cells. J. Neuroimmunol. 96 (1999) 167-181
19. Delgado M., Abad C., Martinez C., Juarranz M.G., Leceta J., Ganea D., and Gomariz R.P. PACAP in immunity and inflammation. Ann. N.Y. Acad. Sci. 992 (2003) 141-157
20. Delgado M., Gonzales-Rey E., and Ganea D. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production in dendritic cells. FASEB J. 18 (2004) 1453-1455
21. Elenkov I.J., Webster E.L., Torpy D.J., and Chrousos G.P. Stress, corticotropin-releasing hormone, glucocorticoids and the immune/inflammatory response: acute and chronic effects. Ann. N.Y. Acad. Sci. 876 (1999) 1-11
22. Ganea D., and Delgado M. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. Arch. Immunol. Ther. Exp. 49 (2001) 101-110
23. Ganea D., and Delgado M. VIP and PACAP as modulators of both innate and adaptive immunity. Crit. Rev. Oral Biol. Med. 13 (2002) 229-237
24. Gardner P. Calcium and T lymphocyte activation. Cell 59 (1989) 15-20
25. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., and Wascheck J.A. Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenyl cyclase activating polypeptide (PACAP). Pharmacol. Rev. 50 (1998) 625-627
26. Markowska M., Mrozkowiak A., and Skwarlo-Sonta K. Influence of melatonin on chicken lymphocytes in vitro: involvement of membrane receptor. Neuroendocrinol. Lett. 23 Suppl. 1 (2002) 67-72
27. Markowska M., Mrozkowiak A., Pawlak J., and Skwarlo-Sonta K. Intracelullar second messenger involved in melatonin signal transduction in chicken splenocytes in vitro. J. Pineal Res. 37 (2004) 207-212
28. Martinez C., Delgado M., Pozo D., Leceta J., Calvo J.R., Ganea D., and Gomariz R.P. VIP and PACAP modulate endotoxin-induced IL6 production by murine peritoneal macrophages. J. Leukoc. Biol. 63 (1998) 591-601
29. Martinez C., Delgado M., Pozo D., Leceta J., Calvo J.R., Ganea D., and Gomariz R.P. VIP and PACAP enhance IL6 release and mRNA levels in resting peritoneal macrophages in vitro and in vivo studies. J. Neuroimmunol. 85 (1998) 155-167
30. Martinez C., Abad C., Delgado M., Arranz A., Juarranz M.G., Rodringuez-Henche N., Brabet P., Laceta J., and Gomariz R.P. Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc. Natl. Acad. Sci. 99 (2002) 1053-1058
31. Martinez-Fuentes A.J., Castano J.P., Garcia-Navarro F., and Malagon M.M. PACAP 38 and PACAP 27 activate common and distinct intracellular signaling pathways to stimulate growth hormone secretion from porcine somatotropes. Endocrinology 139 (1998) 5116-5124
32. Mazzocchi G., Malendowicz L.K., Rebuffat P., Gottardo L., and Nussdorfer G.G. Expression and function of VIP, PACAP and their receptors in the human adrenal gland. JCEM 87 (2002) 2575-2580
33. McCann S.M., Kimura M., Karanth S., Yu W.H., Mastronardi C.A., and Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann. N.Y. Acad. Sci. 917 (2000) 4-18
34. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., and Coy D.H. Isolation of novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164 (1989) 567-574
35. Munck A., and Guyre P.M. Glucocorticoids and immune functions. In: Ader R., Felten D., and Cohen N. (Eds). Psychoneuroimmunology. ed. 2 (1991), New York Academic 447-513
36. Nussdorfer G., and Malendowicz L. Role of VIP and PACAP and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19 (1998) 1443-1467
37. Pozo D. VIP and PACAP-mediated immunomodulation as prospective therapeutic tools. Trends Mol. Med. 9 (2003) 211-217
38. Reubi J.C. In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues: clinical implications. Ann. N.Y. Acad. Sci. 921 (2000) 1-25
39. Sawangjaroen K., Anderson S.T., and Curlewis J.D. Effects of PACAP and VIP on hormone secretion from sheep pituitary cell in vitro. J. Neuroendocrinol. 9 (1997) 279-286
40. Sawisky G.R., and Chang J.P. Intracelullar calcium involved in pituitary adenylate cyclase-activating peptide stimulation of growth hormone and gonadotrophin secretion in goldfish pituitary cells. J. Neuroendocrinol. 17 (2005) 353-371
41. Sherwood N.M., Krueckl S.L., and McRoy J.E. The origin and function of pituitary adenylate cyclase activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 21 (2000) 619-670
42. Turnbull A.V., and River C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: action and mechanisms of action. Physiol. Rev. 79 (1999) 1-71
43. van Pelt L.J., van Zwieten R., Weening R.S., Roos D., Verhoeven A.J., and Bolscher B.G. Limitation on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J. Immunol. Methods 191 (1996) 187-196
44. Vaudry D., Gonzales B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52 (2000) 269-324
45. Yaqoob P., Newsholme E.A., and Calder P.C. The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology 82 (1994) 603-610